Pure Global AI
NCT06391073Not yet recruiting

Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems

Reach Out 2: Randomized Clinical Trial of Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems
Northwestern UniversityClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Hypertension
Drug/Device/Intervention
Self-Measured Blood Pressure Monitoring
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Northwestern University
Location
Flint, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Nov 30, 2028
Enrollment
500 participants
Primary outcome

Change in systolic blood pressure

Summary

Emergency department visits provide an opportunity to identify people with undiagnosed,
 untreated, or uncontrolled high blood pressure. In Reach Out, we will test whether a mobile
 health intervention yields a greater reduction in blood pressure than usual care among
 individuals identified with high blood pressure during a safety-net emergency department
 visit. Subsequently, we will estimate the reduction in heart attack, stroke, and dementia if
 Reach Out were implemented across all U.S. safety-net emergency departments.

ICD-10 classifications
Hypertensive diseasesRenovascular hypertensionSecondary hypertensionOther secondary hypertensionHypertensive heart disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06391073
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06391073 through Pure Global AI's free database. This phase not specified trial is sponsored by Northwestern University and is currently Not yet recruiting. The study focuses on Hypertension. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.